Each peptide has a different escalation pace, different dose steps, and different maintenance ranges
PubMed, doi:10.1038/sj.bjc.6603880
Empagliflozin Improves Parameters of Left Atrial Function in Patients With Type 2 Diabetes - Edited By: Prateek Chopra A post hoc analysis of the EMPA-Hemodynamics study which included 44 participants with type 2 diabetes and no AF/atrial flutter found that empagliflozin was associated with improved LA function after 3 months as assessed by a mean increase from 26.4% to 29% in LA strain reservoir and a mean increase from 10.9% to 12.5% in LA strain contraction phase values compared with placebo
"The effects of L-carnitine supplementation on cardiovascular risk factors in participants with impaired glucose tolerance and diabetes: a systematic review and dose-response meta-analysis." Diabetology & Metabolic Syndrome
Furthermore, the ELF GSH levels that are maintained may in fact be tied to the CS induced depletion of GSH and that the lung may utilize GSH originating from other sources such as the liver and plasma to generate the high levels of ELF GSH
Always consult with your healthcare provider before starting any new medication, particularly if you have multiple sclerosis or other neurological conditions